Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20160321 20169877 1.6 82.5 Palliative (P) 2018-01-29 2019-08-05 DARATUMUMAB 02 N CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 101866424
20160629 20169878 1.6 83.6 Palliative (P) 2021-09-03 2021-09-05 Capecitabine + Streptozocin 02 null CARBOPLATIN + EPIRUBICIN + FLUOROURACIL 101802734
20161356 20169880 1.82 79.35 Palliative (P) 2017-08-22 2017-10-17 STS Rhabdomyosarcoma RMS 2005 IVADo 02 N MITOMYCIN 100087950
20161556 20169881 1.57 78.1 null 2018-03-19 2018-03-19 STS Rhabdo VIT0910 Vinc Irinotecan 02 N CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 101182578
20163011 20169884 1.58 70 03 2019-06-27 2019-06-30 COSMIC TRIAL 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 100465565
20164336 20169885 1.78 108 Curative (C) null 2018-10-16 Bortezomib + CYCLOPHOSPHAMIDE Y null CISPLATIN + FLUOROURACIL + RT 101712263
20164782 20169886 1.55 97 Palliative (P) 2020-05-03 2020-05-03 DARATUMUMAB 02 Y MPV 100187380
20167281 20169887 1.62 null Adjuvant (A) 2017-07-31 2017-08-14 Vinorelbine (oral) 02 N TRASTUZUMAB EMTANSINE 101265092
20167598 20169888 1.65 14.5 Neo-adjuvant (N) 2022-02-01 2022-03-02 INTERAACT trial 2 null CYCLOPHOSPHAMIDE + THALIDOMIDE 100419704
20167684 20169889 1.6 71.1 03 2021-03-22 2021-03-29 Hepatoblastoma VHR Block A Cisplatin/Dox 02 null ATEZOLIZUMAB 100773168
20168615 20169890 1.82 77.6 null 2017-08-27 2017-08-27 CHOP R - 21 days 2 N GEMCARBO 101279647
20169092 20169891 1.75 55.85 Neo-adjuvant (N) 2018-03-02 2018-03-22 Cisplatin +FU +Trastuzumab - Load 02 N CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED 100274021
20170223 20169895 1.75 84.2 null 2021-03-22 2021-04-05 FEC 100 N N IRINOTECAN + RALTITREXED 100854169
20171067 20169897 1.95 54.7 null 2021-05-08 2021-05-22 Bevacizumab + Oxaliplatin +MdG 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 101456253
20171355 20169898 1.89 57.1 Neo-adjuvant (N) 2018-05-04 2018-05-04 BORTEZOMIB + THALIDOMIDE 02 N ACELARATE TRIAL 100547999
20171611 20169899 1.71 73 Palliative (P) 2017-10-02 2017-10-02 Bevacizumab + FLUOROURACIL + IRINOTECAN 02 null MITOMYCIN 100691231
20171685 20169900 1.77 117.5 Neo-adjuvant (N) 2022-02-09 2022-03-12 POMALIDOMIDE 02 null CARBOPLATIN + VINORELBINE 100753451
20172335 20169902 1.84 82 03 2020-10-29 2020-11-01 Radium 223 01 N SCOPE2 TRIAL 101193831
20172650 20169903 1.81 77.7 Palliative (P) 2016-11-22 2017-12-12 DARATUMUMAB 02 null FULVESTRANT + RIBOCICLIB 100315898
20173337 20169905 1.49 50.3 Curative (C) 2018-09-06 2018-09-22 CISPLATIN + RALTITREXED + Trastuzumab 02 null FLUOROURACIL + LIPOSOMAL IRINOTECAN 100025739
20175290 20169906 1.75 57.1 Palliative (P) 2019-06-25 2019-06-26 ECarboF 02 null TEMOZOLOMIDE 101297314
20175860 20169907 1.8 115.9 03 2018-10-15 2018-10-16 CAPE + OXALIPLATIN + TRASTUZUMAB 02 N CETUXIMAB + FLUOROURACIL 101851228
20176343 20169908 1.85 101.5 null 2022-04-03 2022-05-17 CISPLATIN + FLUOROURACIL + RT 01 N CISPLATIN + TEYSUNO 100305895
20176672 20169909 1.48 61 null 2019-10-06 2019-11-04 null 02 N CAPITAL TRIAL 100764749
20176772 20169910 1.8 89.1 Palliative (P) 2017-05-05 2017-07-29 Pazopanib 02 N DABRAFENIB + TRAMETINIB 101801059
20177553 20169913 1.82 70.1 Palliative (P) 2020-06-16 2020-06-26 CISPLATIN + FLUOROURACIL + RT 02 null BEAM 100565509
20178873 20169915 1.65 85.3 Neo-adjuvant (N) 2016-09-05 2016-11-03 CAP + RT 02 null VINCRISTINE 100843706
20180926 20169916 1.55 68.5 Curative (C) 2019-09-09 2019-11-18 TOPOTECAN 02 N HEPATOBLASTOMA VHR BLOCK C CARBO (AUC6.6)/DOX 100350853
20182177 20169918 1.53 61.6 03 2019-01-22 2019-02-01 Capecitabine + Streptozocin 02 N FOCUS4 TRIAL 100068210
20183306 20169921 0 81.55 Neo-adjuvant (N) 2021-04-18 2021-06-29 null 01 N GEMCITABINE + PACLITAXEL 100379481
20183463 20169922 null null Curative (C) 2016-12-17 2016-12-17 Amsacrine + FLUOROURACIL + IRINOTECAN + OXALIPLATIN 01 N MITOMYCIN 101746146
20184308 20169923 1.82 52.6 null 2022-01-20 2022-01-20 EC 02 null TRABECTEDIN 100669532
20184496 20169924 1.86 88.2 null 2018-10-21 2018-10-21 BCG Intravesical 02 N PHITT D CARBOPLATIN/DOXORUBICIN 100023712
20184560 20169925 1.56 70.7 null 2019-08-30 2019-09-05 SCOPE 2 TRIAL 02 N CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN 101540921
20184820 20169926 1.84 93.3 null null 2016-06-26 Gemcitabine + Oxaliplatin 99 null CAPECITABINE + IRINOTECAN + PANITUMUMAB 100129984
20184976 20169927 1.58 74 null 2018-03-20 2018-05-23 BCG Intravesical 02 null RITUXIMAB 100602943
20185965 20169928 1.87 28.6 Disease modification (D) null 2021-11-16 Letrozole + Palbociclib 01 N AXITINIB 101692704
20186389 20169929 1.77 96 null 2019-12-05 2019-12-28 Doxorubicin 75mg/m2 02 null BACILLUS CALMETTE-GUERIN 101404371
20187184 20169930 1.69 91 Palliative (P) 2020-06-03 2020-06-14 DOCETAXEL + GEMCITABINE 01 null MELPHALAN 101518294
20188987 20169932 1.6 66.05 Palliative (P) 2021-03-29 2021-04-18 Rituximab N null BALLAD TRIAL 101684297
20189888 20169933 1.73 115.9 null 2017-11-22 2017-12-06 Cisplatin + Docetaxel 02 N PAZOPANIB 100851622
20189892 20169934 1.6 46.6 Adjuvant (A) 2018-06-12 2018-07-16 Alectinib 02 N CARBOPLATIN + PEMETREXED 100827881
20190292 20169935 1.77 78.85 null 2021-01-18 2021-03-09 CISPLATIN + TRASTUZUMAB 02 null PALBOCICLIB 101266166
20190704 20169936 1.5 81.9 null 2019-03-08 2019-03-22 Cabazitaxel 02 null EW EUROEWING 2012 ARM A VAC 101768149
20190786 20169937 1.87 84.3 null 2019-04-02 2019-04-02 Atezolizumab 02 null CAP + RT 101626160
20191722 20169938 1.65 106 Palliative (P) 2019-08-03 2019-08-10 CISPLATIN + RALTITREXED N N CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 100789396
20192236 20169939 null null 03 2016-01-23 2016-06-05 Palbociclib 02 N PACLITAXEL + TRASTUZUMAB 101713994
20192517 20169940 1.65 11 Palliative (P) 2019-10-24 2019-11-30 Hydroxycarbamide 02 null DARATUMUMAB 100811264
20192633 20169941 1.63 74 Palliative (P) 2018-07-04 2018-07-11 SOTORASIB 02 N HYDROXYCARBAMIDE 100468754
20192799 20169943 1.17 58.2 Palliative (P) 2018-01-25 2018-01-25 null 02 null CISPLATIN + PEMETREXED 101216402